These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24853998)

  • 21. The Relationship Between Plasma Whole Blood Viscosity and Cardiovascular Events in Patients With Chronic Kidney Disease.
    Celik T; Yilmaz MI; Balta S; Ozturk C; Unal HU; Aparci M; Karaman M; Demir M; Yildirim AO; Saglam M; Kilic S; Eyileten T; Aydin İ; Iyisoy A
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):663-670. PubMed ID: 26907084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between IL-10 levels and cardiovascular events in patients with CKD.
    Yilmaz MI; Solak Y; Saglam M; Cayci T; Acikel C; Unal HU; Eyileten T; Oguz Y; Sari S; Carrero JJ; Stenvinkel P; Covic A; Kanbay M
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1207-16. PubMed ID: 24789549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney disease.
    Kennedy DJ; Tang WH; Fan Y; Wu Y; Mann S; Pepoy M; Hazen SL
    J Am Heart Assoc; 2013 Apr; 2(2):e000104. PubMed ID: 23557751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study.
    Suh SH; Oh TR; Choi HS; Kim CS; Bae EH; Ma SK; Oh KH; Han SH; Kim SW;
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular disease, fibrinogen and the acute phase response: associations with lipids and blood pressure in patients with chronic renal disease.
    Irish A
    Atherosclerosis; 1998 Mar; 137(1):133-9. PubMed ID: 9568745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation between paradoxical decrease in high-density lipoprotein cholesterol levels after statin therapy and adverse cardiovascular events in patients with acute myocardial infarction.
    Ota T; Ishii H; Suzuki S; Tanaka A; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T
    Am J Cardiol; 2015 Feb; 115(4):411-6. PubMed ID: 25555656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triglyceride-high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus.
    Zoppini G; Negri C; Stoico V; Casati S; Pichiri I; Bonora E
    Metabolism; 2012 Jan; 61(1):22-9. PubMed ID: 21676418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocyte to HDL Cholesterol Ratio Predicts Coronary Artery Disease Severity and Future Major Cardiovascular Adverse Events in Acute Coronary Syndrome.
    Cetin MS; Ozcan Cetin EH; Kalender E; Aydin S; Topaloglu S; Kisacik HL; Temizhan A
    Heart Lung Circ; 2016 Nov; 25(11):1077-1086. PubMed ID: 27118231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3-5.
    Chiu H; Wu PY; Huang JC; Tu HP; Lin MY; Chen SC; Chang JM
    Sci Rep; 2020 Jul; 10(1):12749. PubMed ID: 32728174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monocyte/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Cetin EH; Cetin MS; Canpolat U; Aydin S; Topaloglu S; Aras D; Aydogdu S
    Biomark Med; 2015; 9(10):967-77. PubMed ID: 26439248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
    Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-HDL-cholesterol to HDL-cholesterol ratio as an independent risk factor for the development of chronic kidney disease.
    Zuo PY; Chen XL; Liu YW; Zhang R; He XX; Liu CY
    Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):582-7. PubMed ID: 25921842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus.
    Joo HJ; Cho SA; Hong SJ; Hur SH; Bae JH; Choi DJ; Ahn YK; Park JS; Choi RK; Choi D; Kim JH; Han KR; Park HS; Choi SY; Yoon JH; Kwon HC; Rha SW; Hwang KK; Jung KT; Oh SK; Lee JH; Shin ES; Kim KS; Kim HS; Lim DS
    Lipids Health Dis; 2016 Nov; 15(1):197. PubMed ID: 27863493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An elevated monocyte-to-high-density lipoprotein-cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI.
    Zhang DP; Baituola G; Wu TT; Chen Y; Hou XG; Yang Y; Pan Y; Ma X; Zheng YY
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial.
    Holme I; Fayyad R; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Larsen ML; Lindahl C; Holdaas H; Pedersen TR;
    J Intern Med; 2010 Jun; 267(6):567-75. PubMed ID: 20141566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triglyceride to high-density lipoprotein cholesterol ratio is associated with increased mortality in older patients on peritoneal dialysis.
    Zhan X; Yang M; Zhou R; Wei X; Chen Y; Chen Q
    Lipids Health Dis; 2019 Nov; 18(1):199. PubMed ID: 31729985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocyte Count/HDL Cholesterol Ratio and Cardiovascular Disease in Patients With Obstructive Sleep Apnea Syndrome: A Multicenter Study.
    Inonu Koseoglu H; Pazarli AC; Kanbay A; Demir O
    Clin Appl Thromb Hemost; 2018 Jan; 24(1):139-144. PubMed ID: 27837155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-density lipoprotein cholesterol and causes of death in chronic kidney disease.
    Navaneethan SD; Schold JD; Walther CP; Arrigain S; Jolly SE; Virani SS; Winkelmayer WC; Nally JV
    J Clin Lipidol; 2018; 12(4):1061-1071.e7. PubMed ID: 29699917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease.
    Holzmann MJ; Jungner I; Walldius G; Ivert T; Nordqvist T; Ostergren J; Hammar N
    Ann Med; 2012 May; 44(3):262-70. PubMed ID: 21114460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.